The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
T-cell inflamed phenotype gene expression signatures to predict clinical benefit from pembrolizumab across multiple tumor types.
 
Sarina Anne Piha-Paul
Research Funding - Abbvie; Bayer; Biomarin; Cerulean Pharma; Curis; Five Prime Therapeutics; GlaxoSmithKline; Helix BioPharma; Incyte; Merck; Novartis; Puma Biotechnology; XuanZhu
 
Jaafar Bennouna
Honoraria - Boehringer Ingelheim; Novartis; Pierre Fabre; roche
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Pierre Fabre; Roche
 
Andrew Albright
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Michael Nebozhyn
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Terrill McClanahan
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Mark Ayers
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jared K. Lunceford
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Patrick Alexander Ott
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Bristol-Myers Squibb
Research Funding - ARMO BioSciences; AstraZeneca; Bristol-Myers Squibb; Merck